PI
PBYI icon

PFG Investments’s Puma Biotechnology PBYI Stock Holding History

PFG Investments’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,000
Closed -$71.4K – 1238
2025
Q4 		$71.4K Sell
12,000
-3,000
-20% -$15.9K ﹤0.01% 1105
2025
Q3 		$79.7K Sell
15,000
-5,000
-25% -$21.2K ﹤0.01% 1063
2025
Q2 		$68.6K Hold
20,000
– – ﹤0.01% 994
2025
Q1 		$59.2K Buy
+20,000
New +$62.6K ﹤0.01% 964

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

PFG Investments's PBYI Position: Q1 2026 in Review

PFG Investments sold out of Puma Biotechnology (PBYI) in Q1 2026, closing a stake of 12,000 shares — an estimated $71.4K sold.

PFG Investments first reported a position in PBYI in Q1 2025 and held it in 4 quarters. The position peaked at $79.7K in Q3 2025. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • PFG Investments reported no remaining Puma Biotechnology position as of Q1 2026 after selling out during the quarter.
  • PFG Investments sold 12,000 Puma Biotechnology shares in Q1 2026, an estimated $71.4K.
  • PFG Investments first reported a position in Puma Biotechnology in Q1 2025 and held it in 4 quarters.
  • PFG Investments's Puma Biotechnology position peaked at $79.7K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.